Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
The market didn't appreciate Amgen's (NASDAQ: AMGN) latest clinical data update, with the biopharma's shares falling more ...
Ulta Beauty price target raised to $390 from $345 at Citi
Citi analyst Kelly Crago raised the firm’s price target on Ulta Beauty (ULTA) to $390 from $345 and keeps a Neutral rating on the shares. The firm anticipates a Q3 earnings beat when Ulta reports on ...